CD8A and hepatocellular carcinoma: Single-cell analysis of primary HCC and recurrent HCC showed that CD8+ T cells and DCs were increased in relapsed HCC, and the aberrant expression led to the compromised antitumor immunity (Zhang et al., 2019).